BRD2 and neoplasm: Briefly, after overlapping the fifty-one genes with our two datasets, NAT- and tumor-derived transcriptomes, respectively, the magnitudes of FCs (the lower panel of Fig. 2D) along with P-values (the upper panel of Fig. 2D) underlying differences in gene expressions between RC and nonRC samples were estimated, just in the same way as for estimating NAT-DEGs and tumor-DEGs described in Fig. 2A&B.